Castillo L, Ulloa M T, Martínez M A, Silva W, Seoane M, Maldonado A, Castillo P
Departamento de Salud, Instituto de Salud Pública de Chile.
Rev Med Chil. 1994 Sep;122(9):986-92.
This report characterizes a multiresistant Vibrio Cholerae O1 strain, isolated from a patient with cholera, and investigates the mechanism of resistance. The analyzed strain was resistant to tetracycline, chloramphenicol and trimethoprim-sulfamethoxazole. The resistance was mediated by a 101 megadalton plasmid that was transferred to the resultant of a conjugation assay between the multiresistant V. Cholerae strain and E. coli C-600 used as receptor strain, that acquired the triple resistance of the parental strain. The resistant V. cholerae strain had a Ogawa serotype, El Tor biotype and toxigenic capacity, demonstrated by ELISA and latex agglutination techniques. The biochemical features of the strain were identical to those of susceptible strains, except for the resistance to 10 and 150 ug o 129 vibriostatic factor. The emergence of plasmid mediated resistance to drugs of choice in the treatment of cholera must alert Chilean and Latin American health authorities, considering the cholera will continue affecting the region.
本报告对从一名霍乱患者身上分离出的多重耐药霍乱弧菌O1菌株进行了特征描述,并研究了其耐药机制。分析的菌株对四环素、氯霉素和甲氧苄啶-磺胺甲恶唑耐药。这种耐药性由一个101兆道尔顿的质粒介导,该质粒通过多重耐药霍乱弧菌菌株与用作受体菌株的大肠杆菌C-600之间的接合试验转移到子代中,子代获得了亲代菌株的三重耐药性。通过ELISA和乳胶凝集技术证明,耐药霍乱弧菌菌株具有小川血清型、埃尔托生物型和产毒能力。该菌株的生化特征与敏感菌株相同,只是对10和150微克的129弧菌抑菌因子耐药。鉴于霍乱将继续影响该地区,质粒介导的对霍乱治疗中首选药物的耐药性的出现必须引起智利和拉丁美洲卫生当局的警觉。